Thyroid Diseases

Abstract

Clinical Practice Guidelines are developed to be of assistance to health care professionals by providing guidance and recommendations for particular areas of practice. The Guidelines should not be considered inclusive of all proper approaches or methods, or exclusive of others. The Guidelines cannot guarantee any specific outcome, nor do they establish a standard of care. The Guidelines are not intended to dictate the treatment of a particular patient. Treatment decisions must be made based on the independent judgment of health care providers and each patient's individual circumstances. The Endocrine Society of Sri Lanka makes no warranty, express or implied, regarding the Guidelines and specifically excludes any warranties of merchantability and fitness for a particular use or purpose. The Society shall not be liable for direct, indirect, special, incidental, or consequential damages related to the use of the information contained herein. Endocrine Society of Sri Lanka thanks the Abbott Laboratories for the unrestricted grant to develop and publish the Thyroid Guidelines.

Meal replacement as a weight loss strategy for night shift workers with obesity: a protocol for a randomized controlled trial

“…To accommodate a 20% dropout rate,we therefore needed to recruit 22 participants in each intervention group. Hence, a total of 44 adults with obesity (BMI > 25kg/m 2 ) will be recruited for the study [24]. The formula used for sample size calculation is presented below;…”

Update on subclinical thyroid disease

“…Although virtually all experts recommend treatment of patients with serum TSH concentrations >10 mU/L, the routine treatment of asymptomatic patients with TSH values between 4.5 and 10 mU/L remains controversial. The clinical guidelines by the Endocrine Society of Sri Lanka recommends to repeat TSH in 3 to 6 months in patients with TSH between 4.5-10 mU/L prior to commencement of thyroxine (4). In view of data linking subclinical hypothyroidism with atherosclerosis and myocardial infarction, young or middle aged patients with TSH between 4.5 and 10 mU/L can be treated in the presence of symptoms, a goiter, high titers of antithyroid peroxidase antibodies and dyslipidaemia.…”

“…The American Thyroid Association divides patients into high risk and low risk categories prior to treatment (8). The recently published clinical guidelines by the Endocrine Society of Sri Lanka recommends treatment as follows (4).…”